Australian Government: Australian Institute of Health and Welfare METeOR Home Page

National Bowel Cancer Screening Program (NBCSP)

Identifying and definitional attributes

Item type:Help on this termData Source
Description:Help on this term

The National Bowel Cancer Screening Program (NBCSP) began in 2006. It aims to reduce morbidity and mortality from bowel cancer by actively recruiting and screening the eligible target population for early detection or prevention of the disease. In 2014, the Australian Government announced that the program would be expanded to offer free 2-yearly screening for all Australians aged 50–74.

The target population list is compiled from those who were registered as an Australian citizen or migrant in the Medicare enrolment file, or were registered with a Department of Veterans’ Affairs gold card. A phased roll-out was used with different age groups being invited to screen across different years (as shown in the following table). Two-yearly screening (with all relevant age groups included) was fully rolled out from 1 January, 2019.

NBCSP phases and target populations

Phase Start date End date Target ages (years)
1 7 August 2006 30 June 2008 55 and 65
2 1 July 2008 30 June 2011(a) 50, 55 and 65
2(b) 1 July 2011 30 June 2013 50, 55 and 65
3 1 July 2013 Ongoing 50, 55, 60 and 65
4 1 January 2015   50, 55, 60, 65, 70 and 74
4 1 January 2016   50, 55, 60, 64, 65, 70, 72 and 74
4 1 January 2017   50, 54, 55, 58, 60, 64, 68, 70, 72 and 74
4 1 January 2018   50, 54, 58, 60, 62, 64, 66, 68, 70, 72 and 74
4 1 January 2019   50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72 and 74

(a)  Eligible birth dates, and thus invitations, ended on 31 December 2010.

(b)  Ongoing NBCSP funding commenced.

Note: The eligible population for all Phase 2 and 3 start dates incorporates all those turning the target ages from 1 January of that year onwards.

 

Eligible Australians are sent an invitation to complete a free immunochemical faecal occult blood test (iFOBT) in the privacy of their own home and mail it to a pathology laboratory for analysis. Participants with a positive iFOBT result will be advised to discuss the result with their doctor, who will generally refer them for further investigations, usually a colonoscopy.

Link to data source:Help on this term

http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/bowel-screening-1

Collection and usage attributes

Frequency:Help on this term6-monthly (register snapshot)

Source and reference attributes

Data custodian:Help on this term

Medicare Australia (Medicare Australia merged with the Department of Human Services in 2011)